Five-year survival following a non-small-cell lung cancer diagnosis among Veterans Health Administration patients with schizophrenia and bipolar disorder
VHA patients diagnosed with NSCLC who had schizophrenia experienced greater mortality compared to those without SZ/BP, despite no meaningful differences between the two groups in stage of NSCLC at diagnosis. Further work to understand drivers of this difference (e.g., access to NSCLC treatment) and subsequent interventions are needed.
Authors
- Nicholas W. Bowersox (ORCID: https://orcid.org/0000-0001-9867-4326)
- Phoebe A. Tsao (ORCID: https://orcid.org/0000-0002-8694-3186)
- Benjamin R. Szymanski (ORCID: https://orcid.org/0000-0003-4004-1088)
- Anna L Philibert
- Daniel W. Bradford
Institutions
- University of Michigan (US)
- VA Ann Arbor Healthcare System (US)
- New York State Office of Mental Health (US)
- VA Center for Clinical Management Research (US)
- Ann Arbor VA Medical Center (US)
- Durham VA Medical Center (US)
Publication Details
- Journal
- General Hospital Psychiatry
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1016/j.genhosppsych.2025.04.004
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Prostate Cancer Foundation